We are live on ! Find out more
RXST icon

RxSight

212 hedge funds and large institutions have $1.21B invested in RxSight in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 85 increasing their positions, 61 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,042% more call options, than puts

Call options by funds: $19.8M | Put options by funds: $1.73M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

39% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 61

2.11% more ownership

Funds ownership: 85.54%87.65% (+2.1%)

1% less funds holding

Funds holding: 214212 (-2)

5% less first-time investments, than exits

New positions opened: 40 | Existing positions closed: 42

28% less capital invested

Capital invested by funds: $1.68B → $1.21B (-$464M)

Holders
212
Holders Change
-2
Holders Change %
-0.93%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
40
Increased
85
Reduced
61
Closed
42
Calls
$19.8M
Puts
$1.73M
Net Calls
+$18.1M
Net Calls Change
-$3.51M
Name Holding Trade Value Shares
Change
Change in
Stake
AQR Capital Management
76
AQR Capital Management
Connecticut
$1.72M -$498K -11,045 -18%
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$1.67M +$75K +1,663 +4%
PAMP
78
Polar Asset Management Partners
Ontario, Canada
$1.61M +$2.11M +46,700 New
HF
79
HRT Financial
New York
$1.57M +$2.07M +45,809 New
Verition Fund Management
80
Verition Fund Management
Connecticut
$1.53M +$1.12M +24,907 +127%
NRD
81
Nebula Research & Development
New York
$1.49M +$306K +6,778 +19%
Legal & General Group
82
Legal & General Group
United Kingdom
$1.46M +$178K +3,947 +10%
Franklin Resources
83
Franklin Resources
California
$1.42M -$110K -2,448 -6%
First Trust Advisors
84
First Trust Advisors
Illinois
$1.39M -$3.07M -68,117 -63%
Principal Financial Group
85
Principal Financial Group
Iowa
$1.37M +$175K +3,879 +11%
DAM
86
Doheny Asset Management
California
$1.35M -$1.18M -26,210 -40%
PA
87
Paragon Advisors
Texas
$1.3M +$290K +6,423 +20%
AllianceBernstein
88
AllianceBernstein
Tennessee
$1.28M
Simplex Trading
89
Simplex Trading
Illinois
$1.19M +$1.57M +34,730 New
JP Morgan Chase
90
JP Morgan Chase
New York
$1.18M -$7.13M -158,113 -82%
QT
91
Quantbot Technologies
New York
$1.15M +$363K +8,041 +32%
SEI Investments
92
SEI Investments
Pennsylvania
$1.11M -$155K -3,444 -10%
California State Teachers Retirement System (CalSTRS)
93
California State Teachers Retirement System (CalSTRS)
California
$1.09M +$9.52K +211 +0.7%
Walleye Capital
94
Walleye Capital
New York
$1.08M -$4.44M -98,345 -76%
FRM
95
Fox Run Management
Connecticut
$1.01M +$426K +9,443 +47%
ACM
96
Aquatic Capital Management
Illinois
$1.01M +$39.9K +885 +3%
Wells Fargo
97
Wells Fargo
California
$914K +$20.1K +445 +2%
PP
98
PDT Partners
New York
$902K +$366K +8,116 +45%
LPL Financial
99
LPL Financial
California
$860K +$38.8K +861 +4%
GCP
100
GSA Capital Partners
United Kingdom
$845K +$157K +3,480 +17%

RXST Hedge Fund Activity: Q4 2024 in Review

212 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2024, worth a combined $1.21B — down 28% from $1.68B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of RXST and 40 opened new positions — a net loss of 2 holders — while 61 trimmed existing stakes and 85 added.

The largest buyer was Citadel Advisors, adding an estimated $35.3M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $51.9M sold.

  • 212 institutional investors held RxSight (RXST) as of Q4 2024, down from 214 in Q3 2024.
  • Funds reported $1.21B of RxSight stock for Q4 2024, down 28% quarter-over-quarter.
  • 40 funds opened new RxSight positions in Q4 2024 and 42 closed out, a net change of -2 holders.
  • The largest RxSight buyer in Q4 2024 was Citadel Advisors, an estimated $35.3M added.
  • The largest RxSight seller in Q4 2024 was Lord, Abbett & Co, an estimated $51.9M sold.

Based on aggregated 13F filings for Q4 2024.